HK1248535A1 - Treatment or prevention of infection - Google Patents
Treatment or prevention of infection Download PDFInfo
- Publication number
- HK1248535A1 HK1248535A1 HK18108159.0A HK18108159A HK1248535A1 HK 1248535 A1 HK1248535 A1 HK 1248535A1 HK 18108159 A HK18108159 A HK 18108159A HK 1248535 A1 HK1248535 A1 HK 1248535A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein
- immunogen
- peptide
- gingivalis
- sequence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010900846A AU2010900846A0 (en) | 2010-02-26 | Treatment or prevention of infection | |
| AU2010900846 | 2010-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1248535A1 true HK1248535A1 (en) | 2018-10-19 |
Family
ID=44506081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18108159.0A HK1248535A1 (en) | 2010-02-26 | 2018-06-26 | Treatment or prevention of infection |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9125853B2 (enExample) |
| EP (2) | EP3260135A1 (enExample) |
| JP (1) | JP5977677B2 (enExample) |
| KR (2) | KR20130036185A (enExample) |
| CN (2) | CN104689308B (enExample) |
| AU (1) | AU2011220335B2 (enExample) |
| BR (1) | BR112012021383A2 (enExample) |
| CA (1) | CA2790219C (enExample) |
| HK (1) | HK1248535A1 (enExample) |
| MX (1) | MX342832B (enExample) |
| MY (1) | MY162557A (enExample) |
| NZ (1) | NZ601890A (enExample) |
| RU (1) | RU2617399C2 (enExample) |
| SG (2) | SG183376A1 (enExample) |
| TW (1) | TWI583392B (enExample) |
| WO (1) | WO2011103633A1 (enExample) |
| ZA (1) | ZA201206204B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0811530B1 (pt) | 2007-05-14 | 2019-01-02 | Research Foundation Of State Univ Of New York | composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície |
| WO2010022463A1 (en) * | 2008-08-29 | 2010-03-04 | Oral Health Australia Pty Ltd | Prevention, treatment and diagnosis of p.gingivalis infection |
| US20110104179A1 (en) * | 2009-06-19 | 2011-05-05 | Oral Health Australia Pty Ltd | Protease inhibitory peptides |
| US20170247674A1 (en) * | 2014-10-14 | 2017-08-31 | The Forsyth Institute | Conjugates for delivery to mitochondria |
| KR101587113B1 (ko) * | 2014-10-29 | 2016-01-20 | 경북대학교 산학협력단 | 치주염 유발 장알균(Enterococcus faecalis)을 특이적으로 사멸시키는 신규한 박테리오파지 |
| EP3389704B1 (en) * | 2015-12-15 | 2022-01-26 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Vaccination against diabetes, obesity and complications thereof |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210035A (en) | 1980-05-19 | 1993-05-11 | Board Of Trustees Of Leland Stanford Jr. University | Non-reventing live vaccines |
| US4837151A (en) | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
| US4735801A (en) | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| WO1993014779A1 (en) | 1992-01-30 | 1993-08-05 | Corvas International, Inc. | Trypsin inhibitors |
| JPH0797395A (ja) | 1993-09-28 | 1995-04-11 | Kyowa Medex Co Ltd | ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途 |
| AUPN627595A0 (en) | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| AUPO652897A0 (en) | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
| AUPP893999A0 (en) | 1999-03-01 | 1999-03-25 | Csl Limited | Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| AUPQ485999A0 (en) | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| US8283135B2 (en) * | 2000-06-30 | 2012-10-09 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| GB0114185D0 (en) | 2001-06-12 | 2001-08-01 | Protherics Molecular Design Lt | Compounds |
| GB2370838A (en) | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex |
| US20060142203A1 (en) | 2002-06-26 | 2006-06-29 | Todd Hembrough | Compositions and methods comprising protein activated receptor antagonists |
| US20070036734A1 (en) | 2003-03-17 | 2007-02-15 | Kirin Beer Kabushiki Kaisha | Therapeutic agent for periodontal disease |
| US20050070543A1 (en) * | 2003-07-11 | 2005-03-31 | Pharmacia Corporation | Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ACE inhibitor for the treatment of central nervous system damage |
| DE602004031024D1 (de) | 2003-08-15 | 2011-02-24 | Univ Florida | Die identifikation von polynukleotiden von porphyromonas gingivalis-virulenz zur diagnose, behandlung und beobachtung von periodontalerkrankungen |
| GB0411150D0 (en) * | 2004-05-19 | 2004-06-23 | Queen Mary & Westfield College | Vaccine |
| JP2008510726A (ja) | 2004-08-20 | 2008-04-10 | エントレメッド インコーポレイテッド | プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法 |
| NZ554331A (en) | 2004-09-23 | 2009-04-30 | Univ Melbourne | Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| US7888482B2 (en) | 2006-02-10 | 2011-02-15 | Amgen Inc. | Antibodies that bind PAR-2 |
| JP2009544279A (ja) | 2006-06-27 | 2009-12-17 | オーラル ヘルス オーストラリア ピーティーワイ リミテッド | 歯周病の予防に有用なポルフィロモナス・ジンジバリスポリペプチド |
| ES2432690T3 (es) | 2007-07-12 | 2013-12-04 | Oral Health Australia Pty Ltd | Tratamiento de biopelícula |
| RU2366378C1 (ru) * | 2008-04-07 | 2009-09-10 | Сергей Владимирович Сирак | Способ костной пластики при непосредственной дентальной имплантации |
| US9366673B2 (en) * | 2009-08-02 | 2016-06-14 | Sanofi Pasteur Limited | Porphyromonas gingivalis polypeptides |
-
2011
- 2011-02-23 MY MYPI2012003796A patent/MY162557A/en unknown
- 2011-02-25 SG SG2012061099A patent/SG183376A1/en unknown
- 2011-02-25 EP EP17167876.6A patent/EP3260135A1/en not_active Withdrawn
- 2011-02-25 AU AU2011220335A patent/AU2011220335B2/en active Active
- 2011-02-25 TW TW100106637A patent/TWI583392B/zh not_active IP Right Cessation
- 2011-02-25 MX MX2012009730A patent/MX342832B/es active IP Right Grant
- 2011-02-25 JP JP2012554168A patent/JP5977677B2/ja active Active
- 2011-02-25 CN CN201510084917.9A patent/CN104689308B/zh active Active
- 2011-02-25 CA CA2790219A patent/CA2790219C/en active Active
- 2011-02-25 BR BR112012021383A patent/BR112012021383A2/pt not_active Application Discontinuation
- 2011-02-25 SG SG10201500976XA patent/SG10201500976XA/en unknown
- 2011-02-25 NZ NZ601890A patent/NZ601890A/en not_active IP Right Cessation
- 2011-02-25 WO PCT/AU2011/000206 patent/WO2011103633A1/en not_active Ceased
- 2011-02-25 EP EP11746760.5A patent/EP2538970A4/en not_active Withdrawn
- 2011-02-25 CN CN2011800183736A patent/CN102883744A/zh active Pending
- 2011-02-25 RU RU2012136724A patent/RU2617399C2/ru not_active IP Right Cessation
- 2011-02-25 KR KR1020127022892A patent/KR20130036185A/ko not_active Ceased
- 2011-02-25 KR KR1020177026249A patent/KR20170109685A/ko not_active Ceased
- 2011-02-25 US US13/580,090 patent/US9125853B2/en active Active
-
2012
- 2012-08-17 ZA ZA2012/06204A patent/ZA201206204B/en unknown
-
2018
- 2018-06-26 HK HK18108159.0A patent/HK1248535A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102883744A (zh) | 2013-01-16 |
| JP2013520448A (ja) | 2013-06-06 |
| SG183376A1 (en) | 2012-09-27 |
| RU2012136724A (ru) | 2014-04-10 |
| CN104689308B (zh) | 2020-10-20 |
| RU2617399C2 (ru) | 2017-04-24 |
| SG10201500976XA (en) | 2015-04-29 |
| TW201138813A (en) | 2011-11-16 |
| EP3260135A1 (en) | 2017-12-27 |
| WO2011103633A1 (en) | 2011-09-01 |
| AU2011220335A1 (en) | 2012-09-06 |
| US20130129768A1 (en) | 2013-05-23 |
| ZA201206204B (en) | 2013-05-29 |
| US9125853B2 (en) | 2015-09-08 |
| CN104689308A (zh) | 2015-06-10 |
| KR20170109685A (ko) | 2017-09-29 |
| MX2012009730A (es) | 2013-02-07 |
| EP2538970A4 (en) | 2013-12-18 |
| MY162557A (en) | 2017-06-15 |
| BR112012021383A2 (pt) | 2017-07-25 |
| NZ601890A (en) | 2015-01-30 |
| AU2011220335B2 (en) | 2015-04-02 |
| TWI583392B (zh) | 2017-05-21 |
| KR20130036185A (ko) | 2013-04-11 |
| CA2790219C (en) | 2020-06-30 |
| JP5977677B2 (ja) | 2016-08-24 |
| EP2538970A1 (en) | 2013-01-02 |
| CA2790219A1 (en) | 2011-09-01 |
| MX342832B (es) | 2016-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11572391B2 (en) | Antibodies for prevention, treatment and diagnosis of P. gingivalis infection | |
| HK1248535A1 (en) | Treatment or prevention of infection | |
| AU2011220335A2 (en) | Treatment or prevention of infection | |
| HK1157357B (en) | Prevention, treatment and diagnosis of p.gingivalis infection | |
| HK1157357A (en) | Prevention, treatment and diagnosis of p.gingivalis infection | |
| AU2013203249A1 (en) | Prevention, treatment and diagnosis of P.gingivalis infection |